100693-25-2

Upstream product

• 100671-46-3 C₂₅H₂₉N₂O₉PS 
• 100671-49-6 6-Benzenesulfonyl-4-(dimethoxy-phosphoryloxy)-5-methoxy-7-methyl-3,6-dihydro-pyrrolo[3,2-e]indole-1-carboxylic acid tert-butyl ester 
• 100671-47-4 tert-butyl 3,6-dihydro-4-((dimethoxyphosphinyl)oxy)-5-hydroxy-7-methyl-6-(phenylsulfonyl)benzo<1,2-b:4,3-b'>dipyrrole-1-carboxylate 
• 100671-50-9 4-Acetoxy-6-benzenesulfonyl-5-methoxy-7-methyl-3,6-dihydro-pyrrolo[3,2-e]indole-1-carboxylic acid tert-butyl ester 
• 100671-45-2 tert-butyl 3,4,5,6-tetrahydro-6-(phenylsulfonyl)-4,5-dioxobenzo<1,2-b:4,3-b'>dipyrrole-7-carboxylate 
• 100693-24-1 4-Acetoxy-6-benzenesulfonyl-5-methoxy-7-methyl-3,6-dihydro-pyrrolo[3,2-e]indole-1-carboxylic acid 

Downstream Products

• 100671-51-0 Acetic acid 3-acetyl-6-benzenesulfonyl-5-methoxy-7-methyl-1,2,3,6-tetrahydro-pyrrolo[3,2-e]indol-4-yl ester 
• 107914-19-2 Acetic acid 6-benzenesulfonyl-5-methoxy-7-methyl-1,2,3,6-tetrahydro-pyrrolo[3,2-e]indol-4-yl ester 

Relevant academic research and scientific papers

Studies on the Synthesis of the Antitumor Agent CC-1065. Synthesis of PDE I and PDE II, Inhibitors of Cyclic Adenosine-3',5'-monophosphate Phosphodiesterase Using the 3,3'-Bipyrrole Strategy

In the model series tert-butyl 2,4-pentadienoate was treated with TosCHMeNC/NaH to give the pyrrole 18, which was converted into the 3,3'-bipyrrole 20.Treatment of the pyrrole 20 with oxalyl chloride gave the o-quinone 21, which was reduced and concomitan